THC insider buying and SEC filings, explained
Tenet Healthcare Corp. · CIK 70318
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$71.2M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 14, 2026 | Sale | J. Robert Kerrey (Director) sold 12,010 shares at about $263.72 ($3.2M). Holdings down 71% to 4,794 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 16, 2026 |
| Sep 10, 2026 | Sale | Richard J. Mark (Director) sold 10,000 shares at about $263.42 ($2.6M). Holdings down 28% to 25,121 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 14, 2026 |
| Sep 2, 2026 | Sale | Nadja West (Director) sold 1,152 shares at $258.80 ($298K). Holdings down 5% to 23,653 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 3, 2026 |
| Aug 31, 2026 | Sale | Lisa Y Foo (President / COO) sold 24,000 shares at about $266.32 ($6.4M). Holdings down 75% to 8,053 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 1, 2026 |
| Aug 24, 2026 | Sale | Cecil D. Haney (Director) sold 1,300 shares at $278.03 ($361K). Holdings down 9% to 12,553 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 26, 2026 |
| Aug 24–25, 2026 | Sale | Saumya Sutaria (CEO and Director) sold 100,000 shares between Aug 24 and Aug 25 at about $276.36 ($27.6M). Holdings down 19% to 433,564 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 26, 2026 |
| Aug 6–7, 2026 | Sale | Tammy Romo (Director) sold 7,422 shares between Aug 6 and Aug 7 at about $263.03 ($2.0M). Holdings down 21% to 28,284 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 10, 2026 |
| Aug 5, 2026 | Sale | Roy Blunt (Director) sold 600 shares at about $262.68 ($158K). Holdings down 12% to 4,589 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 7, 2026 |
| Jul 29, 2026 | Sale | Lisa Y Foo (President / COO) sold 10,000 shares at about $258.03 ($2.6M). Holdings down 24% to 32,053 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 31, 2026 |
| Jul 27, 2026 | Sale | Christopher S. Lynch (Director) sold 3,837 shares at $243.44 ($934K). Holdings down 29% to 9,568 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 28, 2026 |
| Jul 27, 2026 | Sale | Paola M Arbour (EVP, Chief Information Officer) sold 10,878 shares at about $243.90 ($2.7M). Holdings down 37% to 18,413 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 28, 2026 |
| Jul 27, 2026 | Sale | James L. Bierman (Director) sold 5,000 shares at about $244.96 ($1.2M). Holdings down 14% to 31,604 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 28, 2026 |
| May 28, 2026 | Sale | J. Robert Kerrey (Director) sold 5,638 shares at about $174.52 ($984K). Holdings down 25% to 16,804 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 29, 2026 |
| May 27, 2026 | Sale | Nadja West (Director) sold 3,000 shares at $177.35 ($532K). Holdings down 11% to 24,805 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 28, 2026 |
| Mar 11, 2026 | Sale | Paola M Arbour (EVP, Chief Information Officer) sold 6,500 shares at about $238.43 ($1.5M). Holdings down 18% to 29,291 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 13, 2026 |
| Mar 9, 2026 | Sale | Thomas W Arnst (EVP, Chief Admin. Officer & GC) sold 8,000 shares at about $238.85 ($1.9M). Holdings down 100% to 12 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 10, 2026 |
| Mar 2, 2026 | Sale | R. Scott Ramsey (Principal Accounting Officer) sold 8,017 shares at about $232.70 ($1.9M). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Sale | Thomas W Arnst (EVP, Chief Admin. Officer & GC) sold 24,000 shares at about $234.04 ($5.6M). Holdings down 75% to 8,012 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Dec 15, 2025 | Sale | Nadja West (Director) sold 2,178 shares at about $197.47 ($430K). Holdings down 7% to 28,480 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 17, 2025 |
| Nov 6, 2025 | Sale | R. Scott Ramsey (Principal Accounting Officer) sold 13,322 shares at about $205.11 ($2.7M). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 7, 2025 |
| Nov 5, 2025 | Sale | Tammy Romo (Director) sold 645 shares at $205.20 ($132K). Holdings down 2% to 34,866 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 7, 2025 |
| Nov 3–4, 2025 | Sale | Tammy Romo (Director) sold 26,855 shares between Nov 3, 2025 and Nov 4, 2025 at about $202.23 ($5.4M). Holdings down 43% to 35,511 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 5, 2025 |
42 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow THC in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.